Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CB | P42338 | 2/20 | 0.40 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.40 |
| ▸ | KIT | P10721 | 1/20 | 0.35 |
| ▸ | KDR | P35968 | 1/20 | 0.35 |
| ▸ | FLT3 | P36888 | 1/20 | 0.35 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.31 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.31 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.31 |
| ▸ | PRKDC | P78527 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15759656 | 0.86 | ALOX5 (0.33) | ALOX5 | |
| SCHEMBL19752407 | 0.86 | ALOX5 (0.33) | KDRALOX5PRKDC | |
| SCHEMBL23027482 | 0.82 | PRKDC (0.35) | PIK3CBPIK3CGALOX5PRKDC | |
| SCHEMBL12419908 | 0.80 | ERBB2 (0.30) | — | |
| SCHEMBL10083826 | 0.80 | ENPP3 (0.32) | ALOX5 | |
| SCHEMBL21698311 | 0.80 | ALDH1A1 (0.33) | — | |
| SCHEMBL12420992 | 0.79 | PRKDC (0.34) | PIK3CBPIK3CGALOX5PRKDC | |
| SCHEMBL10082687 | 0.78 | ALOX5 (0.31) | ALOX5PRKDC | |
| SCHEMBL1755449 | 0.78 | ENPP3 (0.34) | PRKDC | |
| SCHEMBL13050915 | 0.78 | ALOX5 (0.44) | PIK3CBALOX5PRKDC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11730054-B2 | Compound having dibenzofuran and naphthalene structures, and organic electroluminescent element using same | IDEMITSU KOSAN CO., LTD. (JP) | 2023-08-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11730054-B2 | Compound having dibenzofuran and naphthalene structures, and organic electroluminescent element using same | LEF1, TCF4, RPL19 | PIK3CB 4794/4885PIK3CG 4799/4885KIT 2172/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.